95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.27%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.18%
Negative gross profit growth while FSM is at 31.52%. Joel Greenblatt would examine cost competitiveness or demand decline.
-4.08%
Negative EBIT growth while FSM is at 46.45%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.08%
Negative operating income growth while FSM is at 46.45%. Joel Greenblatt would press for urgent turnaround measures.
-2.61%
Negative net income growth while FSM stands at 127.67%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-5.26%
Negative EPS growth while FSM is at 127.52%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-5.26%
Negative diluted EPS growth while FSM is at 127.35%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.02%
Slight or no buybacks while FSM is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.01%
Diluted share reduction more than 1.5x FSM's 0.53%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-100.00%
Dividend reduction while FSM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-11.81%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-9.47%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
40.93%
10Y revenue/share CAGR under 50% of FSM's 102.53%. Michael Burry would suspect a lasting competitive disadvantage.
28.77%
5Y revenue/share CAGR under 50% of FSM's 98.23%. Michael Burry would suspect a significant competitive gap or product weakness.
-9.56%
Negative 3Y CAGR while FSM stands at 14.37%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
50.50%
Positive long-term OCF/share growth while FSM is negative. John Neff would see a structural advantage in sustained cash generation.
81.81%
Below 50% of FSM's 546.56%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-6.37%
Negative 3Y OCF/share CAGR while FSM stands at 38.65%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
62.13%
Net income/share CAGR at 50-75% of FSM's 122.40%. Martin Whitman might question if the firm’s product or cost base lags behind.
180.54%
Below 50% of FSM's 510.88%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
0.46%
Positive short-term CAGR while FSM is negative. John Neff would see a clear advantage in near-term profit trajectory.
62.55%
10Y equity/share CAGR at 50-75% of FSM's 104.96%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
32.72%
5Y equity/share CAGR above 1.5x FSM's 8.50%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
20.48%
3Y equity/share CAGR above 1.5x FSM's 0.62%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-48.46%
Firm’s AR is declining while FSM shows 16.01%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Inventory is declining while FSM stands at 8.43%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.54%
Positive asset growth while FSM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.74%
50-75% of FSM's 2.42%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-4.23%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-28.25%
We cut SG&A while FSM invests at 1.94%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.